Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (STTR [R41/R42])

The summary for the Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (STTR [R41/R42]) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Innovative Toxicity Assays of Pollutants, Therapeutics, and Drugs (STTR [R41/R42])
	CFDA Number:	93.113
	CFDA Description:	Environmental Health
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Environment Food and Nutrition Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-09-007
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Oct 08, 2008
	Creation Date:	Jan 26, 2009
	Original Closing Date for Applications:	Sep 07, 2009
	Current Closing Date for Applications:	Sep 07, 2009
	Archive Date:	Oct 08, 2009
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Information not provided
Grant Description: -Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-006, that encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-09-007.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Research Project Grant (Parent R01); • Research on Research Integrity (R21); • Sleep and Social Environment: Basic Biopsychosocial Processes (R21); • Ethical Legal and Social Implications (ELSI) of Genomic Research Regular Research Program (R01); • Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03...; • Outstanding New Environmental Scientist Award (ONES); • Environmental Health Sciences Core Center Grants; • LEIOMYOMATA UTERI: BASIC SCIENCE AND TRANSLATIONAL RESEARCH; • Disease Investigation through Specialized Clinically-Oriented Ventures in Environmental Research (DI...; • Comparative Biology Elucidation of Environmental Pathways and Susceptibility (R01)